论文部分内容阅读
他巴唑是临床上常用的活性最强的抗甲状腺药物。为正确估价他巴唑每日顿服法是否优于分服法,对145例甲状腺机能亢进患者的大剂量他巴唑顿服法与分服法治疗的近期疗效做了系统对比观察,现报告如下。 1 对象与方法 1.1 对象:145例均为甲亢住院患者,根据服药方法不同分为2组:(1)他巴唑顿服法观察组(简称顿服组)100例,其中男33例,女67例,年龄14～67岁;(2)他巴唑分服法对照组(简称分服组)45例,
Methimazole is the most active anti-thyroid drug commonly used clinically. In order to correctly estimate whether methimazole is superior to sub-dose method, we compared the short-term curative effect of high-dose methimazole and partial-dose in 145 patients with hyperthyroidism. as follows. 1 Subjects and Methods 1.1 Subjects: 145 cases were hospitalized patients with hyperthyroidism, according to different methods of medication was divided into two groups: (1) observation group (Dayton clothing group) 100 cases, including 33 males and females 67 cases, aged 14 to 67 years; (2) 45 cases of methimazole control group (referred to as service group)